Versatis, 700 mg patch 5 pcs

A local anesthetic, acetamide derivative.

It has membrane stabilizing activity, causes blockade of sodium channels of excitable membranes of neurons.

When applied topically it does not irritate tissues and in recommended doses does not affect myocardial contractility and does not slow down AV conduction.

Therapeutic effect when used topically on intact skin is sufficient to relieve pain without a systemic effect.

Indications

Myalgia (muscle pain), Anesthesia, trigeminal neuralgia, Joint pain (arthralgia), Pain, MyositisNeuropathic pain associated with a previous herpes infection (Herpes zoster), postherpetic neuralgia.

Active ingredient

Lidocaine

Composition

One TTS contains lidocaine 700 mg;

Associates:

Water,

Glycerol,

D-sorbitol (70% solution),

Polyacrylic acid (20% solution),

Sodium polyacrylate,

Sodium carboxymethylcellulose,

Propylene glycol,

Urea,

Caolin,

Polyacrylic acid,

Polyacrylate,

Polyacrylic acid,

Polyacrylate./p>

Vinic acid (tartaric acid),

Gelatin,

Polyvinyl alcohol,

Aluminum dihydroxyamino acetate,

Dinatrium edetate,

Methyl parahydroxybenzoate (methylparaben),

Propyl parahydroxybenzoate (propyl paraben).

How to take, the dosage

“The patch is intended for external use.

The patch is applied to the skin in the area of pain once a day for up to 12 hours. No more than three patches can be applied at a time.

If necessary the patch can be cut into pieces before removing the plastic protective film.

The patch should be applied to intact, dry, noninflamed skin (after the complete healing of herpetic rashes) covering the pain area.

Then remove the patch and take a break for at least 12 hours. Do not use the removed patch again.

The patch is glued to the skin immediately after removal from the sachet and removing the plastic film from the adhesive layer. The hair should be trimmed with scissors (not shaved).

The therapy efficiency should be repeatedly evaluated in 2-4 weeks after the treatment beginning.

If during this time the response to therapy is insufficient or the therapeutic effect is determined only by the protective properties of the patch, the treatment should be stopped.

It is necessary to regularly evaluate the effectiveness of therapy to determine the optimal number of simultaneously applied patches needed to cover the area of pain, or to increase the periods between applications of the patch.

The use of Versatis patch under 18 years of age is not recommended.

There are no data on the safety and efficacy of Versatis patch in patients under 18 years of age.

After sticking the patch you should avoid hand contact with the eyes, you should wash your hands immediately.

The used patch contains the active ingredient.

Dispose of Versatis patch immediately after use.

Interaction

Since plasma concentrations of lidocaine are very low, a clinically significant drug interaction is unlikely.

Perhaps use with caution in patients receiving class I antiarrhythmic drugs and other local anesthetics.

Special Instructions

In concomitant use of Versatis with hypnotics and sedatives it is possible to increase the depressant effect on the central nervous system.

Contraindications

• High sensitivity of allergic and non-allergic origin to the active and excipients of the product;
• High sensitivity of allergic and non-allergic origin to local amide anesthetic agents (e.g., bupivacaine, etidocaine, mepivacaine and prilocaine);
• inflammation or skin integrity disorders at the site of patch application (e.g., herpes zoster rash, atopic dermatitis or wounds).

.

Side effects

• headache,
• dizziness,
• numbness of the tongue and oral mucosa,
• decrease in blood pressure,
• decrease in heart rate,
• sensation of burning sensation when the aerosol hits the anaesthetic surface (stops after a few seconds after the onset of anaesthesia.slow heart rate,
• a burning sensation when the aerosol hits the anesthetic surface (stops a few seconds after the onset of anesthesia).

.

Overdose

An overdose of TCA is unlikely, but cannot be completely ruled out, as inappropriate use can lead to higher plasma concentrations than normal.

Possible signs of systemic toxicity would be similar in nature to those following administration of lidocaine as a local anesthetic.

Pregnancy use

Versatis should not be used during pregnancy and lactation (breastfeeding).

Similarities

Lidocaine, Lidocaine-Vial